Innovacorp, Angels Invest in DeCell
DeCell Technologies Inc., a Halifax biotech startup that is improving skin grafts for wound treatment, has landed about $500,000 in investment to finance clinical trials and its first processing system.
President and CEO Paul Gratzer said in an interview Wednesday that the company has landed a $250,000 equity investment from Innovacorp. It has also received financing from private individuals, including long-standing biotech entrepreneur Steve Arless of Montreal, who has joined the company’s board.
Gratzer said the $500,000 financing marks an initial close of DeCell’s seed round, and it